ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $449,000 | -24.5% | 36,086 | -17.0% | 0.00% | -20.0% |
| Q3 2016 | $595,000 | +63.0% | 43,457 | -12.1% | 0.01% | +66.7% |
| Q2 2016 | $365,000 | -0.5% | 49,455 | -13.8% | 0.00% | 0.0% |
| Q1 2016 | $367,000 | +2.2% | 57,374 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $359,000 | +7.2% | 57,374 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $335,000 | -29.3% | 57,374 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $474,000 | -20.5% | 57,374 | -20.7% | 0.00% | -20.0% |
| Q1 2015 | $596,000 | +18.5% | 72,372 | -1.1% | 0.01% | +25.0% |
| Q4 2014 | $503,000 | +27.3% | 73,204 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $395,000 | +75.6% | 73,204 | +107.4% | 0.00% | +50.0% |
| Q2 2014 | $225,000 | -32.6% | 35,300 | -14.8% | 0.00% | -33.3% |
| Q1 2014 | $334,000 | +18.0% | 41,440 | -0.1% | 0.00% | +50.0% |
| Q4 2013 | $283,000 | -62.8% | 41,465 | +0.3% | 0.00% | -71.4% |
| Q3 2013 | $761,000 | +5.3% | 41,357 | +0.1% | 0.01% | 0.0% |
| Q2 2013 | $723,000 | – | 41,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |